- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06056882
Simultaneous CLE Guided Crybiopsy in Patients With Pulmonary Nodules
February 9, 2024 updated by: Daniela Gompelmann, University of Vienna
It is planned to use the CLE probe and cryoprobe simultaneously after detection of the round focus.
It is planned to include 5 patients with suspected central airway invading lung carcinoma and 15 patients with suspected peripheral lung carcinoma who have an indication for bronchoscopic histologic confirmation.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Daniela Gompelmann
- Phone Number: 014040047730
- Email: daniela.gompelmann@meduniwien.ac.at
Study Locations
-
-
-
Vienna, Austria
- Recruiting
- Medical University of Vienna
-
Contact:
- Daniela Gompelmann
- Phone Number: 0043 1 40400 47730
- Email: daniela.gompelmann@meduniwien.ac.at
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients with indication for bronchoscopy and biopsy for suspicious pulmonary lesions
Description
Inclusion Criteria:
- >18 years
- Suspicion of lung carcinoma
Exclusion Criteria:
- Known allergy to fluorescin
- Pregnancy and/or lactation
- No discontinuation of ß-blocker 12 hours before intervention possible
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Study group
|
During bronchoscopy, that is performed for suspicious pulmonary lesions, it is planned to use the CLE probe and cryoprobe simultaneously wafter detection of the round focus.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Safety and feasibility
Time Frame: during bronchoscopy procedure
|
Advers events
|
during bronchoscopy procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Daniela Gompelmann, Medical University of Vienna
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 20, 2023
Primary Completion (Estimated)
March 31, 2024
Study Completion (Estimated)
June 30, 2024
Study Registration Dates
First Submitted
September 20, 2023
First Submitted That Met QC Criteria
September 20, 2023
First Posted (Actual)
September 28, 2023
Study Record Updates
Last Update Posted (Actual)
February 12, 2024
Last Update Submitted That Met QC Criteria
February 9, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1.1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Disease
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Kırıkkale UniversityRecruitingCOPD (Chronic Obstructive Pulmonary Disease)Turkey
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease, COPDNew Zealand
-
Astellas Pharma Global Development, Inc.CytokineticsCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
AstraZenecaParexel International Ltd; Cognizant Technology Solution; Center for Information... and other collaboratorsCompletedChronic Obstructive Pulmonary Disease COPDUnited States, Canada, France, Russian Federation, Ukraine, Hungary, Bulgaria
-
University of ZurichNational Center of Cardiology and Internal Medicine named after academician...CompletedChronic Obstructive Pulmonary Disease (COPD)Kyrgyzstan
Clinical Trials on CLE-guided cryobiopsy
-
M.D. Anderson Cancer CenterCompletedLung CarcinomaUnited States
-
Shandong UniversityUnknown
-
University of CalgaryCompleted
-
University Hospital, EssenMarta CuyásActive, not recruitingInterstitial Lung DiseaseGermany
-
Assiut UniversityUnknown
-
Guangzhou Institute of Respiratory DiseaseUnknownSafety | Transbronchial Cryobiopsy | Freezing Time | Diagnostic YieldChina
-
Clexio Biosciences Ltd.RecruitingChronic Pruritus in Adult Subjects With Notalgia Paresthetica (NP)United States
-
Brno University HospitalRecruitingBiliary Tract Carcinoma | Biliary ObstructionCzechia
-
Guangzhou Institute of Respiratory DiseaseUnknownDiffuse Parenchymal Lung DiseasesChina